🟢 Axsome Therapeutics is trading 13.7% up in after-hours trading with no clear company-specific explanation reported

Axsome Therapeutics is trading at $191.41, up 13.70%, with no clear company-specific announcement explaining the after-hours jump in available October 9 coverage.

• The company’s November 2 earnings date is upcoming, not a same-day results catalyst.
• Before the move, reports described a prolonged losing streak and recent analyst target cuts. Broad indexes rose Friday, but that context does not establish the cause of Axsome Therapeutics’ much larger after-hours gain.